184 related articles for article (PubMed ID: 37691854)
1. A Druggable FOXA1-Glucocorticoid Receptor Transcriptional Axis Drives Tumor Growth in a Subset of Non-Small Cell Lung Cancer.
Dorso M; Patel PT; Pankov A; Boyer JA; Soni RK; Del Priore IS; Hayatt O; Kulick A; Hagen CJ; de Stanchina E; Junttila MR; Daemen A; Friedman LS; Hendrickson RC; Chandarlapaty S
Cancer Res Commun; 2023 Sep; 3(9):1788-1799. PubMed ID: 37691854
[TBL] [Abstract][Full Text] [Related]
2. Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer.
Helminen L; Huttunen J; Tulonen M; Aaltonen N; Niskanen EA; Palvimo JJ; Paakinaho V
Nucleic Acids Res; 2024 Jan; 52(2):625-642. PubMed ID: 38015476
[TBL] [Abstract][Full Text] [Related]
3. Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions.
Swinstead EE; Miranda TB; Paakinaho V; Baek S; Goldstein I; Hawkins M; Karpova TS; Ball D; Mazza D; Lavis LD; Grimm JB; Morisaki T; Grøntved L; Presman DM; Hager GL
Cell; 2016 Apr; 165(3):593-605. PubMed ID: 27062924
[TBL] [Abstract][Full Text] [Related]
4. FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells.
Sahu B; Laakso M; Pihlajamaa P; Ovaska K; Sinielnikov I; Hautaniemi S; Jänne OA
Cancer Res; 2013 Mar; 73(5):1570-80. PubMed ID: 23269278
[TBL] [Abstract][Full Text] [Related]
5. An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis.
Hight SK; Mootz A; Kollipara RK; McMillan E; Yenerall P; Otaki Y; Li LS; Avila K; Peyton M; Rodriguez-Canales J; Mino B; Villalobos P; Girard L; Dospoy P; Larsen J; White MA; Heymach JV; Wistuba II; Kittler R; Minna JD
Neoplasia; 2020 Aug; 22(8):294-310. PubMed ID: 32512502
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific expression of
Chung YS; Jin HL; Jeong KW
Int J Immunopathol Pharmacol; 2020; 34():2058738420946192. PubMed ID: 32838581
[TBL] [Abstract][Full Text] [Related]
7. Interaction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activity.
Karmakar S; Jin Y; Nagaich AK
J Biol Chem; 2013 Aug; 288(33):24020-34. PubMed ID: 23814048
[TBL] [Abstract][Full Text] [Related]
8. EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells.
Huttunen J; Aaltonen N; Helminen L; Rilla K; Paakinaho V
Cell Mol Life Sci; 2024 Apr; 81(1):160. PubMed ID: 38564048
[TBL] [Abstract][Full Text] [Related]
9. FoxA1 and glucocorticoid receptor crosstalk via histone H4K16 acetylation at a hormone regulated enhancer.
Belikov S; Holmqvist PH; Astrand C; Wrange Ö
Exp Cell Res; 2012 Jan; 318(1):61-74. PubMed ID: 22001115
[TBL] [Abstract][Full Text] [Related]
10. FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter.
Belikov S; Astrand C; Wrange O
Mol Cell Biol; 2009 Oct; 29(20):5413-25. PubMed ID: 19687299
[TBL] [Abstract][Full Text] [Related]
11. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
[TBL] [Abstract][Full Text] [Related]
12. FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer.
Jones D; Wade M; Nakjang S; Chaytor L; Grey J; Robson CN; Gaughan L
Oncotarget; 2015 Oct; 6(30):29782-94. PubMed ID: 26336819
[TBL] [Abstract][Full Text] [Related]
13. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.
Sahu B; Laakso M; Ovaska K; Mirtti T; Lundin J; Rannikko A; Sankila A; Turunen JP; Lundin M; Konsti J; Vesterinen T; Nordling S; Kallioniemi O; Hautaniemi S; Jänne OA
EMBO J; 2011 Sep; 30(19):3962-76. PubMed ID: 21915096
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.
Jin HJ; Zhao JC; Ogden I; Bergan RC; Yu J
Cancer Res; 2013 Jun; 73(12):3725-36. PubMed ID: 23539448
[TBL] [Abstract][Full Text] [Related]
15. High-throughput RNA FISH analysis by imaging flow cytometry reveals that pioneer factor Foxa1 reduces transcriptional stochasticity.
Lalmansingh AS; Arora K; Demarco RA; Hager GL; Nagaich AK
PLoS One; 2013; 8(9):e76043. PubMed ID: 24073287
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
17. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.
Gao S; Chen S; Han D; Wang Z; Li M; Han W; Besschetnova A; Liu M; Zhou F; Barrett D; Luong MP; Owiredu J; Liang Y; Ahmed M; Petricca J; Patalano S; Macoska JA; Corey E; Chen S; Balk SP; He HH; Cai C
Nat Genet; 2020 Oct; 52(10):1011-1017. PubMed ID: 32868907
[TBL] [Abstract][Full Text] [Related]
18. TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth.
Palit SA; Vis D; Stelloo S; Lieftink C; Prekovic S; Bekers E; Hofland I; Šuštić T; Wolters L; Beijersbergen R; Bergman AM; Győrffy B; Wessels LF; Zwart W; van der Heijden MS
Elife; 2019 Dec; 8():. PubMed ID: 31855178
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Genomic Analysis Reveals that the Pioneering Function of FOXA1 Is Independent of Hormonal Signaling.
Glont SE; Chernukhin I; Carroll JS
Cell Rep; 2019 Mar; 26(10):2558-2565.e3. PubMed ID: 30840881
[TBL] [Abstract][Full Text] [Related]
20. FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.
Imamura Y; Sakamoto S; Endo T; Utsumi T; Fuse M; Suyama T; Kawamura K; Imamoto T; Yano K; Uzawa K; Nihei N; Suzuki H; Mizokami A; Ueda T; Seki N; Tanzawa H; Ichikawa T
PLoS One; 2012; 7(8):e42456. PubMed ID: 22879989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]